HNSA (HNSA) News
Follow HNSA (HNSA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
CEO Buys SEK 1.5 Mln Of Hansa Biopharma Shares
Finansinspektionen
EQUITY | Sep 28, 2026, 11:48 AM UTC
M
Hansa Biopharma treats first commercial kidney transplant patient in Australia with Idefirix
Hansa Biopharma (HNSA) announces its first commercial kidney transplant patient treated with Idefirix in Australia.
EQUITY | Aug 18, 2026, 06:13 AM UTC